SCHEMBL2017304

SCHEMBL2017304

COc1cccc(C(=O)NCCC(Cc2ccccc2)N(C)C(=O)c2ccnc(OC)n2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
KLKB1 P03952 1/20 0.41
CTSA P10619 1/20 0.38
HTR1A P08908 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
DRD3 P35462 1/20 0.37
EPHX2 P34913 1/20 0.36
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
SIGMAR1 Q99720 2/20 0.34
OPRM1 P35372 3/20 0.34
OPRK1 P41145 3/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
OPRD1 P41143 1/20 0.34
PYGL P06737 1/20 0.33
CASR P41180 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919106 1.00 HCRTR1 (0.43) HCRTR1HCRTR2KLKB1CTSAHTR1A
SCHEMBL2011408 0.91 HCRTR1 (0.43) HCRTR1HCRTR2KLKB1CTSAHTR1A
SCHEMBL2051291 0.91 HCRTR1 (0.43) HCRTR1HCRTR2CTSAHTR1AHTR2A
SCHEMBL2014592 0.91 HCRTR1 (0.43) HCRTR1HCRTR2CTSAHTR1AHTR2A
SCHEMBL2012216 0.89 EPHX2 (0.47) HCRTR1HCRTR2KLKB1HTR1AHTR2A
SCHEMBL2016502 0.85 HCRTR1 (0.49) HCRTR1HCRTR2KLKB1CTSAHTR1A
SCHEMBL2052690 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2016348 0.83 HCRTR1 (0.61) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2012684 0.81 HCRTR1 (0.42) HCRTR1HCRTR2ALDH1A1HPGDNPC1
SCHEMBL2014058 0.81 HCRTR1 (0.62) HCRTR1HCRTR2KLKB1CTSAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed